Home › Heart Failure › Rhode Island › Providence
Heart Failure clinical trials in Providence, RI
4 studies for Heart Failure are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
RecruitingPhase 3
- Research Site, Providence
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
RecruitingPhase 3
- Research Site, East Providence · 2 mi away
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RecruitingPhase 3
- Providence, RI Investigative Site 10050, Providence
Supporting Health in Veterans With Heart Failure
RecruitingHealthy volunteers welcome
- VA Clinic - Providence, Providence
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY51 studies
- Boston, MA44 studies
- Dallas, TX42 studies
- Houston, TX36 studies
- Cleveland, OH33 studies
- Chicago, IL31 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- St. Louis, MO26 studies
- Durham, NC26 studies
- Kansas City, MO25 studies
- Atlanta, GA25 studies
Other studies in Providence
- Ovarian Cancer15 studies
- Endometrial Cancer14 studies
- Obesity14 studies
- Non-Small Cell Lung Cancer12 studies
- Cancer (all types)12 studies
- Crohn's Disease12 studies
- Ulcerative Colitis11 studies
- Breast Cancer11 studies
- Acute Myeloid Leukemia10 studies
- Metastatic Cancer9 studies
- Overweight9 studies
- Alzheimer's Disease8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.